Showing results (321-330 of 5,917) with videos related to
Sort By:
Pageof 592
Arthritis Research & Therapy|August 25, 2021
Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritisYoshiya Tanaka, Tsutomu Takeuchi, Hiroyuki Izutsu, et al.Arthritis Research & Therapy|August 25, 2021
Incidence and severity of G6PI-induced arthritis are not increased in genetically distinct mouse strains upon agingNico Andreas, Sylvia Müller, Nicole Templin, et al.Arthritis Research & Therapy|August 25, 2021
Differences and similarities in clinical and functional responses among patients receiving tofacitinib monotherapy, tofacitinib plus methotrexate, and adalimumab plus methotrexate: a post hoc analysis of data from ORAL StrategyTsutomu Takeuchi, Roy Fleischmann, Noriko Iikuni, et al.Arthritis Research & Therapy|August 5, 2021
Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemicL Boekel, F Hooijberg, E H Vogelzang, et al.Arthritis Research & Therapy|August 19, 2022
Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort studyRasiah Thayakaran, Ruchika Goel, Nicola J Adderley, et al.Arthritis Research & Therapy|August 19, 2022
Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapyMichael Gernert, Marc Schmalzing, Hans-Peter Tony, et al.Arthritis Research & Therapy|May 13, 2021
Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosusYuri Hiramatsu, Kentaro Isoda, Takuya Kotani, et al.Arthritis Research & Therapy|August 8, 2022
A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritisRubén Burgos-Vargas, Adalberto Loyola-Sanchez, Sofia Ramiro, et al.Arthritis Research & Therapy|August 23, 2022
Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA studyLouise Hedenstierna, Anna Karin Hedström, Lars Klareskog, et al.Arthritis Research & Therapy|August 10, 2022
Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitisC King, R Patel, C Mendoza, et al.Pageof 592